These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 25903677)
1. Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles. Esfandyari-Manesh M; Mostafavi SH; Majidi RF; Koopaei MN; Ravari NS; Amini M; Darvishi B; Ostad SN; Atyabi F; Dinarvand R Daru; 2015 Apr; 23(1):28. PubMed ID: 25903677 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid). Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829 [TBL] [Abstract][Full Text] [Related]
3. Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel. Manoochehri S; Darvishi B; Kamalinia G; Amini M; Fallah M; Ostad SN; Atyabi F; Dinarvand R Daru; 2013 Jul; 21(1):58. PubMed ID: 23866721 [TBL] [Abstract][Full Text] [Related]
4. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells. Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655 [TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and in vivo study of rhein-loaded poly(lactic-co-glycolic acid) nanoparticles for oral delivery. Yuan Z; Gu X Drug Des Devel Ther; 2015; 9():2301-9. PubMed ID: 25960633 [TBL] [Abstract][Full Text] [Related]
6. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin. Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909 [TBL] [Abstract][Full Text] [Related]
7. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles. Wu J; Zhang J; Deng C; Meng F; Zhong Z Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935 [TBL] [Abstract][Full Text] [Related]
8. Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation. Godara S; Lather V; Kirthanashri SV; Awasthi R; Pandita D Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110576. PubMed ID: 32228957 [TBL] [Abstract][Full Text] [Related]
9. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells. Mitra M; Misra R; Harilal A; Sahoo SK; Krishnakumar S Mol Vis; 2011; 17():2724-37. PubMed ID: 22065926 [TBL] [Abstract][Full Text] [Related]
10. Enhanced Cellular Cytotoxicity and Antibacterial Activity of 18-β-Glycyrrhetinic Acid by Albumin-conjugated PLGA Nanoparticles. Darvishi B; Manoochehri S; Esfandyari-Manesh M; Samadi N; Amini M; Atyabi F; Dinarvand R Drug Res (Stuttg); 2015 Dec; 65(12):617-23. PubMed ID: 25607747 [TBL] [Abstract][Full Text] [Related]
11. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Sun B; Ranganathan B; Feng SS Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Win KY; Feng SS Biomaterials; 2006 Apr; 27(10):2285-91. PubMed ID: 16313953 [TBL] [Abstract][Full Text] [Related]
13. Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy. Dong Y; Feng SS Int J Pharm; 2007 Sep; 342(1-2):208-14. PubMed ID: 17560058 [TBL] [Abstract][Full Text] [Related]
14. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts. Lim HJ; Nam HY; Lee BH; Kim DJ; Ko JY; Park JS Biotechnol Prog; 2007; 23(3):693-7. PubMed ID: 17465527 [TBL] [Abstract][Full Text] [Related]
15. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations. Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936 [TBL] [Abstract][Full Text] [Related]
16. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related]
17. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response. Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314 [TBL] [Abstract][Full Text] [Related]
18. [Surface-modified paclitaxel-loaded nanoparticles as local delivery system for the prevention of vessel restenosis]. Mei L; Song CX; Jin X; Che YZ; Jin Z; Sun HF Yao Xue Xue Bao; 2007 Jan; 42(1):81-6. PubMed ID: 17520813 [TBL] [Abstract][Full Text] [Related]
19. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Jackson JK; Hung T; Letchford K; Burt HM Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895 [TBL] [Abstract][Full Text] [Related]
20. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles. Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]